Quantcast
Last updated on April 18, 2014 at 10:16 EDT

Latest Diagnoplex SA Stories

2014-02-28 04:21:53

LAUSANNE, Switzerland, February 28, 2014 /PRNewswire/ -- Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe and Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer announced today the Swiss market launch of Colox(R), a non-invasive screening test for colorectal cancer. Colox(R) is offered as a service by Unilabs' clinical diagnostic service laboratories in Switzerland. Additional countries within Unilabs'...

2013-09-18 04:23:00

LAUSANNE, Switzerland, September 18, 2013 /PRNewswire/ -- Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer and Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe, signed a collaboration agreement to commercialize Colox(R), a minimally invasive colorectal cancer assay within the Unilabs network. The test will be available initially in the Swiss and Swedish markets. The agreement combines...

2011-01-18 02:00:00

LAUSANNE, Switzerland, January 18, 2011 /PRNewswire/ -- Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Group(TM) announced today that Diagnoplex has closed a series A financing extension with Debiopharm Group(TM). Subject to certain milestones, Debiopharm Group(TM) has committed to invest a substantial amount in the company, half of which upfront. Investors in the CHF 10 million A-round were Novartis Venture Fund, NeoMed, and Initiative Capital...